Midatech Pharma is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines.
Driven by a team of scientists, engineers, and pharmaceutical development specialists, and led by an experienced management team, Midatech is progressing a pipeline of differentiated therapeutics in areas of high unmet need for the benefit of patients.
Core to Midatech’s strength is its highly experienced and dedicated team.
The Midatech team benefits from cross-functional expertise including formulation science, pharmaceutical development, and dynamic process engineering. With over 10 years’ experience of working together the team have translated multiple programmes from concept to clinic across three distinct technology platforms and apply extensive knowledge and expertise to deliver rapid R&D innovation and value creation.
Midatech Pharma is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The Company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.
Midatech’s ordinary shares are traded on the Alternative Investment Market (AIM) of the London Stock Exchange under the ticker symbol MTPH (CUSIP number GB00BKT14T00). Midatech’s American Depositary Shares trade on the NASDAQ Capital Market in the United States under the symbol MTP (CUSIP No. 59564R302).Investors Area